Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy

References

• VinikAIThe metabolic basis of atherogenic dyslipidemiaClin Cornerstone200572–3273516473258
   PubMedGoogle Scholar
• SaydahSHFradkinJCowieCCPoor control of risk factors for vascular disease among adults with previously diagnosed diabetesJAMA2004291333534214734596
   PubMed Web of Science ®Google Scholar
• AdielsMOlofssonSOTaskinenMRBorenJOverproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndromeArterioscler Thromb Vasc Biol20082871225123618565848
   PubMed Web of Science ®Google Scholar
• KontushAChapmanMJAntiatherogenic small, dense HDL – guardian angel of the arterial wall?Nat Clin Pract Cardiovasc Med20063314415316505860
   PubMedGoogle Scholar
• BrownSAHutchinsonRMorrisettJPlasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) StudyArterioscler Thromb1993138113911588343489
   PubMed Web of Science ®Google Scholar
• CastelliWPGarrisonRJWilsonPWAbbottRDKalousdianSKannelWBIncidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham StudyJAMA198625620283528383773200
   PubMed Web of Science ®Google Scholar
• GottoAMJrBrintonEAAssessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and updateJ Am Coll Cardiol200443571772414998606
   PubMed Web of Science ®Google Scholar
• RosensonRSBrewerHBJrChapmanMJHDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular eventsClin Chem201157339241021266551
   PubMed Web of Science ®Google Scholar
• El HarchaouiKvan der SteegWAStroesESValue of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population StudyJ Am Coll Cardiol200749554755317276177
   PubMed Web of Science ®Google Scholar
• Toft-PetersenAPTilstedHHAaroeJSmall dense LDL particles – a predictor of coronary artery disease evaluated by invasive and CT-based techniques: a case-control studyLipids Health Dis2011102121262005
   PubMed Web of Science ®Google Scholar
• KraussRMIs the size of low-density lipoprotein particles related to the risk of coronary heart disease?JAMA2002287671271311851524
   PubMed Web of Science ®Google Scholar
• CromwellWCOtvosJDKeyesMJLDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study – implications for LDL managementJ Clin Lipidol20071658359219657464
   PubMed Web of Science ®Google Scholar
• OtvosJDCollinsDFreedmanDSLow-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention TrialCirculation2006113121556156316534013
   PubMed Web of Science ®Google Scholar
• ArsenaultBJLemieuxIDespresJPHDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population studyAtherosclerosis2009206127628119268944
   PubMed Web of Science ®Google Scholar
• FreedmanDSOtvosJDJeyarajahEJBarboriakJJAndersonAJWalkerJARelation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery diseaseArterioscler Thromb Vasc Biol1998187104610539672064
   PubMed Web of Science ®Google Scholar
• AsztalosBFCupplesLADemissieSHigh-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring StudyArterioscler Thromb Vasc Biol200424112181218715388521
   PubMed Web of Science ®Google Scholar
• LamarcheBMoorjaniSCantinBDagenaisGRLupienPJDespresJPAssociations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Quebec Cardiovascular StudyArterioscler Thromb Vasc Biol1997176109811059194760
   PubMed Web of Science ®Google Scholar
• AsztalosBFLe MaulfFDallalGEComparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteinsAm J Cardiol200799568168517317371
   PubMed Web of Science ®Google Scholar
• InsullWJrTothPPSuperkoHRCombination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapyVasc Health Risk Manag201061065107521191426
   PubMedGoogle Scholar
• BergeKGCannerPLCoronary drug project: experience with niacin. Coronary Drug Project Research GroupEur J Clin Pharmacol199140 Suppl 1S49512044644
   PubMed Web of Science ®Google Scholar
• InsullWJrBasileJNVoANJiangPThakkarRPadleyRJEfficacy and safety of combination therapy with niacin extended-release and simvastatin versus atorvastatin in patients with dyslipidemia: The SUPREME StudyJ Clin Lipidol20093210911821291800
   PubMed Web of Science ®Google Scholar
• FreedmanDSOtvosJDJeyarajahEJSex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham StudyClin Chem20045071189120015107310
   PubMed Web of Science ®Google Scholar
• OtvosJDMeasurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopyClin Lab2002483–417118011934219
   PubMedGoogle Scholar
• AIM-HIGH InvestigatorsThe role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: Rationale and study design. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH)Am Heart J20111613471477e47221392600
   PubMed Web of Science ®Google Scholar
• TanCEFosterLCaslakeMJRelations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipemic men and womenArterioscler Thromb Vasc Biol19951511183918487583563
   PubMed Web of Science ®Google Scholar
• KontushAChapmanMJFunctionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosisPharmacol Rev200658334237416968945
   PubMed Web of Science ®Google Scholar
• MorganJCareyCLincoffACapuzziDHigh-density lipoprotein subfractions and risk of coronary artery diseaseCurr Atheroscler Rep20046535936515296702
   PubMedGoogle Scholar
• BarterPKasteleinJNunnAHobbsRHigh density lipoproteins (HDLs) and atherosclerosis; the unanswered questionsAtherosclerosis2003168219521112801602
   PubMed Web of Science ®Google Scholar
• AsztalosBZhangWRoheimPSWongLRole of free apolipoprotein A-I in cholesterol efflux. Formation of pre-alpha-migrating high-density lipoprotein particlesArterioscler Thromb Vasc Biol1997179163016369327755
   PubMed Web of Science ®Google Scholar
• KontushAChantepieSChapmanMJSmall, dense HDL particles exert potent protection of atherogenic LDL against oxidative stressArterioscler Thromb Vasc Biol200323101881188812920049
   PubMed Web of Science ®Google Scholar
• AshbyDTRyeKAClayMAVadasMAGambleJRBarterPJFactors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cellsArterioscler Thromb Vasc Biol1998189145014559743234
   PubMed Web of Science ®Google Scholar
• RosensonRSOtvosJDFreedmanDSRelations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trialAm J Cardiol2002902899412106834
   PubMed Web of Science ®Google Scholar
• VillinesTCStanekEJDevinePJThe ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment durationJ Am Coll Cardiol201055242721272620399059
   PubMed Web of Science ®Google Scholar
• BrownBGZhaoXQChaitASimvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary diseaseN Engl J Med2001345221583159211757504
   PubMed Web of Science ®Google Scholar